反应详情

A solution of 9a-butyl-7-methoxy-4-methyl-1,2,9,9a-tetrahydro-3H-fluoren-3-one (76 mg, 0.267 mmol) in anhydrous CH2Cl2 (2 mL) was placed under a nitrogen atmosphere, cooled in an ice bath, and stirred while 1M BBr3 in CH2Cl2 (0.80 mL, 0.80 mmol) was added by syringe. The cooling bath was removed and the mixture was stirred at room temperature for 2 hours. The mixture was partitioned between EtOAc (20 mL) and water (20 mL) containing 2N HCl (2 mL). The organic phase was washed with brine (10 mL), dried over MgSO4, filtered, and evaporated under vacuum to an oil. This material was purified by preparative layer chromatography on a 0.1×20×20 cm silica gel GF plate using 5% MeOH in CH2Cl2 as the developing solvent. The product band was eluted with 10% MeOH in CH2Cl2 and the eluant evaporated under vacuum to give an oil which was lyophilized from benzene to afford 9a-butyl-7-hydroxy-4-methyl-1,2,9,9a-tetrahydro-3H-fluoren-3-one as an amorphous solid.

1. temperaturecooled in an ice bath
2. additionwas added by syringe
3. customThe cooling bath was removed
4. customThe mixture was partitioned between EtOAc (20 mL) and water (20 mL)
5. additioncontaining 2N HCl (2 mL)
6. washThe organic phase was washed with brine (10 mL)
7. dry with materialdried over MgSO4
8. filtrationfiltered
9. customevaporated under vacuum to an oil
10. customThis material was purified by preparative layer chromatography on a 0.1×20×20 cm silica gel GF plate
11. washThe product band was eluted with 10% MeOH in CH2Cl2
12. customthe eluant evaporated under vacuum
13. customto give an oil which